Figure 3
From: Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan

Percentage of nine AEs associated with nivolumab by outcome.
From: Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan

Percentage of nine AEs associated with nivolumab by outcome.